4
Changes in Ownership
Protalix BioTherapeutics, Inc. Filed Acc 0001385113-25-000005
Director sold 168 shares at $1.87 ($314)
From the SEC's structured data for this filing
Trades in this filing
| Insider | Date | Transaction | Shares | Price | Value | Owned after | D/I |
|---|---|---|---|---|---|---|---|
| Bar-Shalev Amos Director | 2025-11-18 | Sale | −168 | $1.87 | $314 | 0 | D |
| Open-market sales · 168 sh · avg $1.87 · $314 | |||||||
Loading xslF345X05/form4-11192025_091151.xml…